Kyle D. Holen
Impact in
- Oncology top 1%
- Pancreatic and Hepatic Oncology Research
- Lung Cancer Research Studies
- PARP inhibition in cancer therapy
- Geriatrics and Gerontology top 2%
Papers in
- Co-authors
- Leonard B. Saltz (3 shared papers)Herbert Chen (8 shared papers)George Wilding (18 shared papers)Glenn Liu (6 shared papers)Charles Erlichman (8 shared papers)Joel Picus (6 shared papers)Noelle K. LoConte (20 shared papers)Ellen Hollywood (1 shared paper)
- Journals
- Journal of Clinical Oncology (36 papers)Cancer Chemotherapy and Pharmacology (12 papers)Investigational New Drugs (12 papers)Neuro-Oncology (11 papers)The Oncologist (4 papers)
- Partner nations
- United StatesAustraliaNetherlands
In The Last Decade
Kyle D. Holen
125 papers receiving 3.2k citations
Peers
Comparison fields: 5 of 105
- Oncology 1.6k
- Geriatrics and Gerontology 132
- Genetics 250
- Cancer Research 287
- Neurology 273
Countries citing papers authored by Kyle D. Holen
This map shows the geographic impact of Kyle D. Holen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle D. Holen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle D. Holen more than expected).
Fields of papers citing papers by Kyle D. Holen
This network shows the impact of papers produced by Kyle D. Holen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle D. Holen. The network helps show where Kyle D. Holen may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle D. Holen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 126 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 217 | |
| 2 | 2010 | 210 | |
| 3 | 2002 | 210 | |
| 4 | 2008 | 151 | |
| 5 | 2007 | 132 | |
| 6 | 2008 | 130 | |
| 7 | 2009 | 108 | |
| 8 | 2016 | 86 | |
| 9 | 2015 | 78 | |
| 10 | 2016 | 77 | |
| 11 | 2011 | 74 | |
| 12 | Beyond taxanes: a review of novel agents that target mitotic tubulin and microtubules, kinases, and kinesins. | 2009 | 72 |
| 13 | 2008 | 70 | |
| 14 | 2011 | 67 | |
| 15 | 2011 | 65 | |
| 16 | 2010 | 62 | |
| 17 | 2005 | 61 | |
| 18 | 2014 | 61 | |
| 19 | 2010 | 60 | |
| 20 | 2017 | 57 |
About Kyle D. Holen
Kyle D. Holen is a scholar working on Oncology, Genetics, Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 126 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (29 papers), Colorectal Cancer Treatments and Studies (24 papers), Glioma Diagnosis and Treatment (21 papers), Microtubule and mitosis dynamics (12 papers), Neuroendocrine Tumor Research Advances (11 papers), Neuroblastoma Research and Treatments (9 papers), Lung Cancer Research Studies (9 papers) and Cancer, Hypoxia, and Metabolism (9 papers). The work is most often cited by research in Oncology (1.6k citations), Geriatrics and Gerontology (132 citations), Genetics (250 citations), Cancer Research (287 citations) and Neurology (273 citations). Kyle D. Holen has collaborated with scholars based in United States, Australia and Netherlands. Frequent co-authors include Leonard B. Saltz, Herbert Chen, George Wilding, Glenn Liu, Charles Erlichman, Joel Picus, Noelle K. LoConte, Ellen Hollywood, Axel-Rainer Hanauske and Sam Joseph Lubner. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, Investigational New Drugs, Neuro-Oncology and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.